← FDA Drug Approvals (Drugs@FDA)

NOVANTRONE

NDA · New Drug Application · Sponsor: SERONO INC · Approved 2000-10-13

Drug application

FDA Application #

NDA021120

Application type

New Drug Application

Brand name

NOVANTRONE

Generic name

Mitoxantrone Hydrochloride

Active ingredients

MITOXANTRONE HYDROCHLORIDE

Dosage form

INJECTABLE

Route

INJECTION

Marketing status

Discontinued

Sponsor

SERONO INC

First approval

2000-10-13

Source

Authoritative

Drugs@FDA application overview

Machine

JSON-LD · Markdown